peripheral neuropathy, although nerve conduction studies are not mentioned). This resting tremor is almost invariably accompanied by an additional postural tremor.
Although this 'neuropathic' tremor is well recognized in neurological circles, its pathophysiological basis is unclear, since its presence and severity seem to bear no simple relationship to deafferentation, particularly in respect to posterior column sensation'. Indeed, a central, but immunologically mediated, contribution cannot be entirely ruled out.
Despite this disagreement concerning the underlying defect, I fully agree that every patient with an unusual tremor and signs of a peripheral neuropathy should have their serum proteins (including immunoglobulin levels) determined. Finally, I suggest that a more appropriate title might be 'Pseudoparkinsonian tremor and dysgammaglobulinaemic polyneuropathy'. N QUINN NeurolI984; The authors reply below:
Institute of Neurology
Dr Quinn provides interesting information regarding tremor in patients with dysgammaglobulinaemic polyneuropathy and he suggests that our patient did indeed have a 'neuropathic' tremor as opposed to a tremor of central origin.
While accepting that the chronic sensory lower limb neuropathy in our patient may have been secondary to monoclonal gammopathy, we would stress that the sudden origin of a 'pill-rolling' tremor in the upper limbs coinciding with a grossly elevated plasma viscosity is highly suggestive of a central vascular incident. Dalakas et al.1 suggest that there may be a central contribution (immunologically mediated) to the tremor associated with dysgammaglobulinaemic neuropathy. Their patients, however, tended to improve with immunosuppressive therapy whereas the tremor in our patient did not improve with therapy.
With regard to Dr Quinn's title suggestion, our term 'Parkinsonian' is used adjectively and provides an acceptable description of the tremor: the prefix 'pseudo' suggests a tremor bearing no resemblance to that associated with Parkinson's disease and this would be false in this instance. In addition, the history oflongstanding alcohol abuse precludes the use of the suggested latter half of the title, ie 'dysgammaglobulinaemic neuropathy'. Insight and psychosis We read with interest the discussion paper on Insight and Psychosis by Anthony S David <May 1990 JRSM, p 325). We have been attempting to operationalize the concept of insight in schizophrenic patients, and have devised a scale that quantifies insightlessness, Like Dr David, we consider that insight has several dimensions, including attitude to psychiatric illness both past and present, and attitude to treatment. Dr David's inclusion of the ability of the patient to re-label unusual mental events as pathological, as a separate dimension, is, we believe, appropriate. However, compliance with treatment (along with the patient's response to changing symptoms) should be seen not as dimensions of insight, but rather as related events. As Dr David and others have demonstrated! the correlation between insight and compliance is limited. The mechanisms underlying dimunition of insight remain obscure. Insightlessness may be regarded as:
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( 1) a normal phenomenon, insofar as many people demonstrate limited insight into certain characteristics of their personality and behaviour; (2) a defence mechanism (denial);
(3) a delusional phenomenon; (4) a feature of the schizophrenic defect state: and (5) a specific defect of cognition.
Given that the direct measurement of components of insightlessness is not possible, our scale attempts to derive an overall measure, based on a semistructured interview, concerning the attitude of the patient to five parameters. These are the appropriateness of clinical management and placement, the treatment prescribed, the existence of a psychiatric disorder, the behaviour in response to symptoms, and the attitude to previous episodes of illness. Preliminary findings indicate that the score so derived correlates well with a global clinical impression of insight based on prior knowledge of the patient. was an addition to the manuscript, written at any time up to 10 years later than the main body of the text. I believe that the flow of the handwriting is similar to that of Harvey's treatise De motu locali animalium, dated 1627. This argument, however, is likely to appeal only to palaeographers. The overwhelming argument is that in the whole of the rest of the manuscript, there are no remarks implying or requiring a knowledge ofthe circulation and there are many which reveal ignorance of the circulation. This was Harvey's position in 1616.
